Lotus Eye Hospital & Institute Ratios

Lotus Eye Hospital & Institute Ltd Ratios

The Lotus Eye Hospital & Institute Ltd Ratios page provides a complete fundamental analysis of Lotus Eye Hospital & Institute Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Lotus Eye Hospital & Institute Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Lotus Eye Hospital & Institute Ltd (NSE: LOTUSEYE, BSE: 532998) is currently trading at ₹98.22, with a market capitalization of ₹2.11B. As a major player in the Health services sector and Medical/Nursing services industry, Lotus Eye Hospital & Institute Ltd remains a key stock for fundamental analysis using Lotus Eye Hospital & Institute Ltd Ratios.

Lotus Eye Hospital & Institute Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Lotus Eye Hospital & Institute Ltd P/E ratio currently stands at 196.62, making it one of the most tracked metrics in Lotus Eye Hospital & Institute Ltd Ratios.

Historically, the Lotus Eye Hospital & Institute Ltd P/E ratio has shown strong fluctuations:

• 2024: 196.62
• 2023: 40.32
• 2022: 29.62
• 2021: 37.18
• 2020: 55.57

The rising Lotus Eye Hospital & Institute Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Lotus Eye Hospital & Institute Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 2.42.

Historical P/B trend:

• 2024: 2.42
• 2023: 1.98
• 2022: 2.10
• 2021: 2.03

Lotus Eye Hospital & Institute Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Lotus Eye Hospital & Institute Ltd P/S ratio currently stands at 2.93, an important part of Lotus Eye Hospital & Institute Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 2.93
• 2023: 2.44
• 2022: 2.57
• 2021: 2.85

The rising Lotus Eye Hospital & Institute Ltd P/S ratio indicates improved revenue valuation by investors.

Lotus Eye Hospital & Institute Ltd Price to Cash Flow Ratio (P/CF)

The Lotus Eye Hospital & Institute Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 53.80.

Historical Lotus Eye Hospital & Institute Ltd Price to Cash Flow Ratio:

• 2024: 53.80
• 2023: 19.31
• 2022: 25.39
• 2021: 23.53
• 2020: 28.43

The rising Lotus Eye Hospital & Institute Ltd Price to Cash Flow Ratio indicates premium valuation based on cash flow.

Lotus Eye Hospital & Institute Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Lotus Eye Hospital & Institute Ltd EV currently stands at ₹1.45B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 1.45B
• 2023: 1.12B
• 2022: 1.13B
• 2021: 1.03B

Lotus Eye Hospital & Institute Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Lotus Eye Hospital & Institute Ltd EV/EBITDA ratio is currently 40.64, a key metric in Lotus Eye Hospital & Institute Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 40.64
• 2023: 16.62
• 2022: 14.61
• 2021: 17.39

Higher Lotus Eye Hospital & Institute Ltd EV/EBITDA suggests premium valuation.

Lotus Eye Hospital & Institute Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Lotus Eye Hospital & Institute Ltd D/E ratio is currently 0.06, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.06
• 2023: 0.02
• 2022: 0.01
• 2021: 0.02

Lotus Eye Hospital & Institute Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Lotus Eye Hospital & Institute Ltd ROE currently stands at 1.24%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 1.24
• 2023: 4.98
• 2022: 7.27
• 2021: 5.56

Declining ROE indicates pressure on profitability.

Lotus Eye Hospital & Institute Ltd Ratios Analysis Summary

The Lotus Eye Hospital & Institute Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Lotus Eye Hospital & Institute Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Lotus Eye Hospital & Institute Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.